ICure Pharm Inc.
ICure Pharm Inc. operates in Soft Drinks & Non-alcoholic Beverages.
ICure Pharm Inc. (175250) - Net Assets
Latest net assets as of : ₩- KRW
Based on the latest financial reports, ICure Pharm Inc. (175250) has net assets worth ₩- KRW as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩-) and total liabilities (₩-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ICure Pharm Inc. - Net Assets Trend (None–None)
This chart illustrates how ICure Pharm Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ICure Pharm Inc. (None–None)
The table below shows the annual net assets of ICure Pharm Inc. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ICure Pharm Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ICure Pharm Inc. Competitors by Market Cap
The table below lists competitors of ICure Pharm Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mineral Hill Industries Ltd
PINK:MHIFF
|
$14.06K |
|
EVOKE PLC
LSE:EVOK
|
$14.07K |
|
Solutiance AG
XETRA:SLSA
|
$14.07K |
|
ENvue Medical Inc.
NASDAQ:FEED
|
$14.08K |
|
REALORD GROUP HLDGS (CUV.SG)
STU:CUV
|
$14.04K |
|
79GL
LSE:79GL
|
$14.02K |
|
Hermana Holding ASA
OL:HERMA
|
$14.02K |
|
Coffee Stain Group B
ST:COFFEE-B
|
$14.02K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ICure Pharm Inc.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ICure Pharm Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ICure Pharm Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ICure Pharm Inc.'s net assets metrics with peer companies in the Personal Products industry.
No peer company data available for comparison.